 | • レポートコード：MRC2-11QY04730 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多発性硬化症における幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（静脈内、脳室内）市場規模、用途別（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症（SPMS）、進行型再発性多発性硬化症（PRMS））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多発性硬化症における幹細胞治療の競争状況、市場シェア ・世界の多発性硬化症における幹細胞治療市場：種類別市場規模 2015年-2020年（静脈内、脳室内） ・世界の多発性硬化症における幹細胞治療市場：種類別市場規模予測 2021年-2026年（静脈内、脳室内） ・世界の多発性硬化症における幹細胞治療市場：用途別市場規模 2015年-2020年（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症（SPMS）、進行型再発性多発性硬化症（PRMS）） ・世界の多発性硬化症における幹細胞治療市場：用途別市場規模予測 2021年-2026年（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症（SPMS）、進行型再発性多発性硬化症（PRMS）） ・北米の多発性硬化症における幹細胞治療市場分析：米国、カナダ ・ヨーロッパの多発性硬化症における幹細胞治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多発性硬化症における幹細胞治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多発性硬化症における幹細胞治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多発性硬化症における幹細胞治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：American CryoStem、Athersys、Celgene Cellular Therapeutics、Cell Cure Neurosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.
The introduction of mesenchymal stem cells therapy is one of the most promising investigational approach to treat multiple sclerosis, the global multiple sclerosis market will witness growth in the forthcoming years. it has been observed that the American cryostem and celgene cellular therapeutics have their stem cell therapy candidates for the treatment of multiple sclerosis in phase I stage of development.
Market Analysis and Insights: Global Stem Cell Therapy for Multiple Sclerosis Market
The global Stem Cell Therapy for Multiple Sclerosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Stem Cell Therapy for Multiple Sclerosis Scope and Market Size
Stem Cell Therapy for Multiple Sclerosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Multiple Sclerosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
American CryoStem
Athersys
Celgene Cellular Therapeutics
Cell Cure Neurosciences
…
Market segment by Type, the product can be split into
Intravenous
Intracerebroventricular
Market segment by Application, split into
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Progressive Relapsing Multiple Sclerosis (PRMS)
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue
1.4 Market by Type
1.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intravenous
1.4.3 Intracerebroventricular
1.5 Market by Application
1.5.1 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2020 VS 2026
1.5.2 Relapsing-Remitting Multiple Sclerosis (RRMS)
1.5.3 Primary Progressive Multiple Sclerosis (PPMS)
1.5.4 Secondary Progressive Multiple Sclerosis (SPMS)
1.5.5 Progressive Relapsing Multiple Sclerosis (PRMS)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Perspective (2015-2026)
2.2 Global Stem Cell Therapy for Multiple Sclerosis Growth Trends by Regions
2.2.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Stem Cell Therapy for Multiple Sclerosis Historic Market Share by Regions (2015-2020)
2.2.3 Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Stem Cell Therapy for Multiple Sclerosis Market Growth Strategy
2.3.6 Primary Interviews with Key Stem Cell Therapy for Multiple Sclerosis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Market Size
3.1.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue (2015-2020)
3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio
3.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Multiple Sclerosis Revenue in 2019
3.3 Stem Cell Therapy for Multiple Sclerosis Key Players Head office and Area Served
3.4 Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
3.5 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Type (2015-2020)
4.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
5.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
6.2 Stem Cell Therapy for Multiple Sclerosis Key Players in North America (2019-2020)
6.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
6.4 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
7.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Europe (2019-2020)
7.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
7.4 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
8 China
8.1 China Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
8.2 Stem Cell Therapy for Multiple Sclerosis Key Players in China (2019-2020)
8.3 China Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
8.4 China Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
9.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Japan (2019-2020)
9.3 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
9.4 Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
10.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
10.4 Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
11 India
11.1 India Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
11.2 Stem Cell Therapy for Multiple Sclerosis Key Players in India (2019-2020)
11.3 India Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
11.4 India Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size (2015-2020)
12.2 Stem Cell Therapy for Multiple Sclerosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020)
12.4 Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 American CryoStem
13.1.1 American CryoStem Company Details
13.1.2 American CryoStem Business Overview
13.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Introduction
13.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020))
13.1.5 American CryoStem Recent Development
13.2 Athersys
13.2.1 Athersys Company Details
13.2.2 Athersys Business Overview
13.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Introduction
13.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
13.2.5 Athersys Recent Development
13.3 Celgene Cellular Therapeutics
13.3.1 Celgene Cellular Therapeutics Company Details
13.3.2 Celgene Cellular Therapeutics Business Overview
13.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Introduction
13.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
13.3.5 Celgene Cellular Therapeutics Recent Development
13.4 Cell Cure Neurosciences
13.4.1 Cell Cure Neurosciences Company Details
13.4.2 Cell Cure Neurosciences Business Overview
13.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Introduction
13.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020)
13.4.5 Cell Cure Neurosciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Stem Cell Therapy for Multiple Sclerosis Key Market Segments
Table 2. Key Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue
Table 3. Ranking of Global Top Stem Cell Therapy for Multiple Sclerosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous
Table 6. Key Players of Intracerebroventricular
Table 7. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2015-2020)
Table 11. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Stem Cell Therapy for Multiple Sclerosis Market Growth Strategy
Table 17. Main Points Interviewed from Key Stem Cell Therapy for Multiple Sclerosis Players
Table 18. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players (2015-2020)
Table 20. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2019)
Table 21. Global Stem Cell Therapy for Multiple Sclerosis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
Table 24. Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Type (2015-2020)
Table 28. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2021-2026)
Table 29. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Application (2015-2020)
Table 30. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Stem Cell Therapy for Multiple Sclerosis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 34. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 36. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 38. Europe Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 40. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 42. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 44. China Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 46. China Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 47. China Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 48. China Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 49. China Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 50. Japan Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 52. Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 54. Japan Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 58. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 60. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 62. India Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 64. India Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 65. India Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 66. India Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 67. India Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Stem Cell Therapy for Multiple Sclerosis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Stem Cell Therapy for Multiple Sclerosis Market Share (2019-2020)
Table 70. Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Stem Cell Therapy for Multiple Sclerosis Market Share by Type (2015-2020)
Table 72. Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Stem Cell Therapy for Multiple Sclerosis Market Share by Application (2015-2020)
Table 74. American CryoStem Company Details
Table 75. American CryoStem Business Overview
Table 76. American CryoStem Product
Table 77. American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (Million US$)
Table 78. American CryoStem Recent Development
Table 79. Athersys Company Details
Table 80. Athersys Business Overview
Table 81. Athersys Product
Table 82. Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (Million US$)
Table 83. Athersys Recent Development
Table 84. Celgene Cellular Therapeutics Company Details
Table 85. Celgene Cellular Therapeutics Business Overview
Table 86. Celgene Cellular Therapeutics Product
Table 87. Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (Million US$)
Table 88. Celgene Cellular Therapeutics Recent Development
Table 89. Cell Cure Neurosciences Company Details
Table 90. Cell Cure Neurosciences Business Overview
Table 91. Cell Cure Neurosciences Product
Table 92. Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2015-2020) (Million US$)
Table 93. Cell Cure Neurosciences Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Features
Figure 3. Intracerebroventricular Features
Figure 4. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2020 VS 2026
Figure 5. Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies
Figure 6. Primary Progressive Multiple Sclerosis (PPMS) Case Studies
Figure 7. Secondary Progressive Multiple Sclerosis (SPMS) Case Studies
Figure 8. Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies
Figure 9. Stem Cell Therapy for Multiple Sclerosis Report Years Considered
Figure 10. Global Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions: 2020 VS 2026
Figure 12. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players in 2019
Figure 15. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2019
Figure 17. North America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
進行型再発性多発性硬化症治療の世界市場（～2026年） Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Progressive R…- 多発性硬化症治療の世界市場（～2026年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
- 多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
- 多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 一次進行型多発性硬化症治療の世界市場（～2026年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Primary Progressi…